FindTrial
Sign In

TO DETERMINE WHETHER CLINICAL OUTCOME IS BETTER WHEN TREATMENT IS DECIDED ON BASIS OF AGE AND FOLLICULAR STIMULATING HORMONE AS GUIDE TO TREATMENT OR ANTIMULLERIAN HORMONE VALUES IN IN VITRO FERTILISATION PATIENTS.

Compare clinical outcome in conventional ART protocol and novel AMH tailored protocol in ART a prospective randomised controlled trail

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/11/003139
Enrollment
200
Registered
2012-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- INFERTILITY

Interventions

Intervention1: ART PROTOCOL AND DOSE IS DECIDED ON BASIS OF AMH AND CONVENTIONAL METHODS: Person in first cycle of art , the dose and protocol is decided according to conventional ie fsh value and amh

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: patients on IST cycle ART both ovaries visualised severe endometriosis excluded

Exclusion criteria

Exclusion criteria: oncology patients severe endometriosis AMH 0.5

Design outcomes

Primary

MeasureTime frame
clinical pregnancy per cycle startedTimepoint: APRIL 2012 - APRIL 2014—

Secondary

MeasureTime frame
number of oocytes yield cycle cancellation to cycle yield et percycle started ohss leading to cycle cancellationTimepoint: 6weeks—

Countries

India

Contacts

Public ContactDr mousumi acharya

CMC HOSPITAL AND COLLEGE, VELLORE

draleyammatk@hotmail.com9443630074

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026